KAYLA PFANNENSTIEL: Open Payments
NPI 1821489808 · WESTWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 11 payments from 7 companies in 2025. Trend: 2023 $569 · 2024 $504 · 2025 $754
Food & beverage: $655Education: $99
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 4 | $290 |
| Astellas Pharma US Inc | 1 | $127 |
| Genmab U.S., Inc. | 1 | $124 |
| Celgene Corporation | 1 | $102 |
| ABBVIE INC. | 2 | $60 |
| Legend Biotech USA Inc. | 1 | $30 |
| Incyte Corporation | 1 | $20 |
Products named: REZUROCK, Cresemba, BREYANZI, EPKINLY, CARVYKTI, JAKAFI.
Industry payments across KS — which companies pay providers there.
